Literature DB >> 9755926

The cost of tuberculosis to patients in Sierra Leone's war zone.

N Gibson1, F Boillot, H Jalloh.   

Abstract

OBJECTIVE: To evaluate how the extreme poverty of the patients and the poor salaries of the staff combined to increase the cost of treatment to patients within the subsidised national tuberculosis programme in Sierra Leone. DESIGN/
SETTING: From September to December of 1994, semi-structured interviews were conducted with 72 patients and 17 staff of the National Leprosy and Tuberculosis Control Programme of Sierra Leone, a screening and treatment programme funded by international donors.
RESULTS: Although some extra costs were indeed incurred within the subsidized national tuberculosis treatment programme, they were much lower than those incurred during the pre-programme period when the patients sought intermittent help from a wide range of traditional and biomedical sources within the plural healing continuum. The national politico-economic crisis, and the consequent poverty of most patients, impeded compliance with and sustainability of treatment, even within the formal subsidised treatment programme.
CONCLUSIONS: More money was spent by patients on treatment in the months/years preceding entry into the national tuberculosis programme. Many factors retarded entry, including poor communications, misinformation, malpractice by health professionals, and displacement resulting from chronic internal warfare. The war intensified all factors that predispose to tuberculosis and retarded access to treatment. Supra-programme cost, or 'corruption,' was minimal due to the poverty of health professionals, with a few salient exceptions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9755926

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  9 in total

1.  Factors associated with delayed tuberculosis test-seeking behavior in the Peruvian Amazon.

Authors:  Carolyn M Ford; Angela M Bayer; Robert H Gilman; Dami Onifade; Colleen Acosta; Lilia Cabrera; Carlos Vidal; Carlton A Evans
Journal:  Am J Trop Med Hyg       Date:  2009-12       Impact factor: 2.345

Review 2.  Treatment and prevention of multidrug-resistant tuberculosis.

Authors:  I Bastian; R Colebunders
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

3.  Tuberculosis and nutrition: disease perceptions and health seeking behavior of household contacts in the Peruvian Amazon.

Authors:  M R Baldwin; P P Yori; C Ford; D A J Moore; R H Gilman; C Vidal; E Ticona; C A Evans
Journal:  Int J Tuberc Lung Dis       Date:  2004-12       Impact factor: 2.373

4.  Can Malawi's poor afford free tuberculosis services? Patient and household costs associated with a tuberculosis diagnosis in Lilongwe.

Authors:  Julia R Kemp; Gillian Mann; Bertha Nhlema Simwaka; Felix Ml Salaniponi; Stephen Bertel Squire
Journal:  Bull World Health Organ       Date:  2007-08       Impact factor: 9.408

Review 5.  Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.

Authors:  Yoko V Laurence; Ulla K Griffiths; Anna Vassall
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

6.  The indirect cost due to pulmonary Tuberculosis in patients receiving treatment in Bauchi State-Nigeria.

Authors:  Nisser Ali Umar; Richard Fordham; Ibrahim Abubakar; Max Bachmann
Journal:  Cost Eff Resour Alloc       Date:  2012-05-11

Review 7.  Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa--a systematic review.

Authors:  Devra M Barter; Stephen O Agboola; Megan B Murray; Till Bärnighausen
Journal:  BMC Public Health       Date:  2012-11-14       Impact factor: 3.295

8.  Patients are paying too much for tuberculosis: a direct cost-burden evaluation in Burkina Faso.

Authors:  Samia Laokri; Maxime Koiné Drabo; Olivier Weil; Benoît Kafando; Sary Mathurin Dembélé; Bruno Dujardin
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

Review 9.  Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review.

Authors:  Tadayuki Tanimura; Ernesto Jaramillo; Diana Weil; Mario Raviglione; Knut Lönnroth
Journal:  Eur Respir J       Date:  2014-02-13       Impact factor: 16.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.